CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.03
-0.41 (-7.54%)
At close: Jun 1, 2026, 4:00 PM EDT
4.860
-0.170 (-3.38%)
Pre-market: Jun 2, 2026, 8:37 AM EDT
CNS Pharmaceuticals Employees
CNS Pharmaceuticals had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$3,297,258
Market Cap
7.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2024 | 5 | 0 | - | 4 | 1 |
| Dec 31, 2023 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2022 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2021 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| PMGC Holdings | 34 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| Purple Biotech | 10 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Creative Medical Technology Holdings | 4 |
CNSP News
- 13 days ago - CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress - Accesswire
- 13 days ago - CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders - TheFly
- 14 days ago - CNS Pharmaceuticals Registration statement: Registration filing - Filings
- 18 days ago - CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year - TheFly
- 18 days ago - CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months - TheFly
- 19 days ago - CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress - Accesswire
- 19 days ago - CNS Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 19 days ago - CNS Pharmaceuticals Earnings release: Q1 2026 - Filings